Voloridge Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.4M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $13.8M | Buy |
|
|||||
|
2024
Q1 | $5.94M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $617K | Buy |
|
|||||
|
2023
Q2 | $207K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $388K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.11M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $12.5M | Buy |
|
|||||
|
2020
Q1 | $4.79M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $11M | Buy |
|
|||||
|
2019
Q2 | $11.8M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $4.11M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $21.9M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $23.3M | Sell |
|
|||||
|
2016
Q1 | $35.2M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $27.2M | Buy |
|
|||||
|
2015
Q2 | $1.82M | Sell |
|
|||||
|
2015
Q1 | $28.3M | Buy |
|
|||||
|
2014
Q4 | $592K | Sell |
|
|||||
|
2014
Q3 | $2.47M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $5.29M | Buy |
|